Company / SG&A per Share
NOVAVAX INC SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.98
FY2025
5-year range
$0.98 / $5.45
FY2021-FY2025
Trend
-59.4%
vs FY2024
Sector context
#124 of 210
Health Care
What the data says
At $0.98, NOVAVAX INC's sg&a per share ranks #87 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $0.07 in FY2016 to $5.45 in FY2023.
Based on SEC 10-K filings.
0.98 in FY2025 with a 5-year CAGR of -26.2%.
Improved from $5.45 to $0.98 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -20.0%
- 5-Year CAGR
- -26.2%
- 10-Year CAGR
- -
Sector benchmark
#87 of 210 in Health CareTop 41% of 210This company $0.98 Sector average $29.50
▼
-96.7% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 59.4% year-over-year.
- Ranks #124 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.98 | -59.4% |
| FY2024 | $2.42 | -55.7% |
| FY2023 | $5.45 | +184.5% |
| FY2022 | $1.92 | -54.4% |
| FY2021 | $4.20 | -6.4% |
| FY2020 | $4.49 | +150.6% |
| FY2019 | $1.79 | +1145.1% |
| FY2018 | $0.14 | +26.6% |
| FY2017 | $0.11 | +54.0% |
| FY2016 | $0.07 | +19.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026